ArticleScientific reports2025
Prediction model for growth trends of subpleural subsolid nodules using CT radiomics and radiological features.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Assessment of risk factors in persistent subsolid pulmonary nodules based on CT dynamic follow-up.BMC medical imaging · 2026Article
- A narrative review on CT-based evaluation and prediction of lung nodule growth: current status and future directions.Translational lung cancer research · 2026Review
- Predicting pulmonary nodule growth from a single time point: a fusion model of radiomics and deep learning to optimize follow-up strategies.Journal of thoracic disease · 2026Article
- Narrative review: the research advances of artificial intelligence in the prediction of pulmonary nodule growth.Journal of thoracic disease · 2026Review
- PredictMed-CDSS: Artificial Intelligence-Based Decision Support System Predicting the Probability to Develop Neuromuscular Hip Dysplasia.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Subpleural subsolid nodules (SSNs) pose challenges in early malignant transformation risk stratification, leading to over-surveillance or delayed treatment. To develop a radiological-radiomics combined model for predicting growth of subpleural SSNs and optimizing individualized follow-up strategies. This retrospective study included 494 subpleural SSNs (training set: 345; test set: 149) with ≥ 3 years follow-up CT. Radiological features (nodule type, morphology, pleural retraction) and radiomics features were analyzed. A radiomics score (Radscore) was developed using least absolute shrinkage and selection operator (LASSO) regression, and a combined model integrating radiological and radiomics predictors was constructed. Model performance was evaluated via the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The combined model demonstrated favorable performance in both training (AUC 0.896; 95% CI 0.8505-0.9425) and test sets (AUC 0.842; 95% CI 0.7185-0.9600), outperforming radiological model (train: 0.896 vs. 0.716; test: 0.842 vs. 0.741, all P < 0.05) and showed similar performance to the radiomics model (train: 0.896 vs. 0.857, p = 0.047; test: 0.842 vs. 0.840, p = 0.936). Key predictors included part-solid nodule (PSNs) type (OR 2.359, P = 0.009), irregular morphology (OR 2.917, P = 0.001), and pleural retraction (OR 2.227, P = 0.014). Notably, DCA indicated that the combined model had better clinical utility across a range of decision thresholds (10-90%), offering a higher net benefit for guiding interventions. The combined model effectively predicts subpleural SSNs growth, enabling risk stratification to reduce unnecessary follow-up and prioritize early intervention for high-risk nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.